SIC
BNTC icon

SJS Investment Consulting’s Benitec Biopharma BNTC Stock Holding History

SJS Investment Consulting’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27 Buy
+2
New +$24 ﹤0.01% 2810

Other funds holding BNTC

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SJS Investment Consulting's BNTC Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Benitec Biopharma (BNTC) in Q2 2026: 2 shares worth $27. The stake represents ﹤0.01% of the portfolio and ranks #2810 among its holdings.

7 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • SJS Investment Consulting held 2 shares of Benitec Biopharma worth $27 as of Q2 2026.
  • Benitec Biopharma was a new SJS Investment Consulting position in Q2 2026.
  • Benitec Biopharma made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2810 holding.
  • 7 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.